How do scientists evaluate whether a diagnostic test actually works?
This week's glossary carousel explains:
• Sensitivity
• Specificity
• Accuracy
These measures help determine how effectively a test detects disease while avoiding incorrect results.
#Diagnostics #MedicalResearch #CancerScreening
🎙️Prof. Ellen Heitzer from the Medical Uni Graz was recently featured in a podcast!
• Challenges of early #pancreaticcancer detection
• Liquid Biopsy
• Her research on ctDNA and MRD
• The role of PANCAID
🎧 Listen here (German only): www.springermedizin.at/meduni-graz/...
#liquidbiopsy
This is the way to go! As we are doing w/ @pancaid.bsky.social
Detecting cancer early can dramatically improve outcomes.
This week's glossary carousel explains:
• Diagnosis
• Screening
• Early detection
These concepts are central to ongoing research aimed at improving survival rates for pancreatic cancer.
#EarlyDetection #CancerAwareness #PancreaticCancer
Cancer is not just a collection of tumour cells, it interacts with the body around it.
This week’s glossary carousel explores:
• Metastasis
• The tumour microenvironment
• Tumour vs host cells
#CancerResearch #TumourBiology #PancreaticCancer
Genetics and biological processes can strongly influence cancer development.
This week we explain:
• Hereditary #pancreaticcancer syndromes
• KRAS mutations
• Inflammation
These concepts help researchers understand why certain cancers develop and how they progress.
#CancerBiology #Genetics
New masterclass now available 🎥
Klaus Pantel & Catherine Alix-Panabières provide an in-depth overview of liquid biopsy diagnostics: From early detection to clinical implementation.
Watch here: https://youtu.be/uFuAvdRABTo
#LiquidBiopsy #CancerResearch #PANCAID
🟣 Did you know?
There are different types of pancreatic cancer. The most common is pancreatic ductal adenocarcinoma, which begins in the cells that line the ducts of the pancreas.
👉 Learn more: https://pancreaticcancereurope.eu
Who is more likely to develop #pancreaticcancer? Some individuals have a higher probability of developing the disease due to #genetic predisposition, lifestyle factors, or family history.
This week’s explains:
• Risk factors
• Individuals at risk
• Familial pancreatic cancer (FPC)
#CancerRisk
In this week's glossary carousel we explain:
• Dysplasia
• Lesion
• Pancreatic intraepithelial neoplasia (PanIN)
Understanding these early biological changes helps researchers identify opportunities for earlier detection and prevention.
#PancreaticCancer #CancerResearch #EarlyDetection
Cancer is unique; so must be our research approaches.
On #WorldCancerDay, we highlight @fortee-eu.bsky.social , @pancaid.bsky.social & SATURN3: three research consortia tackling cancer from pediatric care to early detection and tumor heterogeneity.
#UnitedByUnique #WCD2026
🚨 500,000 #pancreaticcancer deaths in 2020. The biggest challenge: We can’t diagnose it in time. #WorldCancerDay reminds us that every diagnosis remains a race against time
And we’re committed to develop a biomarker panel that can reliably detect PDAC at its earliest stages
#UnitedByUnique #WCD2026
What does “cell-free DNA” or “PanIN” mean?
Our new PANCAID Glossary explains key #pancreaticcancer and research terms in clear, accessible language.
👉 pancaid-project.eu/for-patients...
Thanks to all teams for input and to @pce-europe.bsky.social for checking the entries for accessibility!
Thrilled to welcome Queen Mary University of London (@qmul.bsky.social) as an associated partner in PANCAID! QMUL contributes to WP3 and WP2, bringing expertise in biomarker analysis and data-driven methods.
#HorizonEU #MissionCancer
As the year comes to a close, let’s take a moment to reflect on our achievements of 2025.
The year's highlights include:
✅ 2 scientific articles
✅ Stakeholder Dialogue Event, bringing together 55 participants from 21 countries and & organisations
✅ Meaningful collaborations with other EU projects
We’re excited to welcome Eberhard Karls University Tübingen (@unituebingen.bsky.social) to the PANCAID consortium! Their expertise in WP2 strengthens our biomarker research and supports progress in early detection of #pancreaticcancer.
#HorizonEU
📺 Happening now! @scienceinnovation.ec.europa.eu is hosting "Advancing cancer care: personalised treatment and innovation"
Prof. Klaus Pantel is panelist in the session "From Detection to Decision: Cutting-Edge Diagnostics in Precision Cancer Care."
👉 Watch here: www.youtube.com/live/z3qA1nQ...
Excited that Prof. Klaus Pantel was speaker at the Inaugural EUnetCCC Educational Seminar in Barcelona yesterday, contributing "Liquid Biopsy: From Discovery to Clinical Implementation"
#EUnetCCC #LiquidBiopsy #pancreaticcancer #precisiononcology #EUfunded
Thank you to the European Cancer Organisation for showcasing our project at the #EuropeanCancerSummit 2025!
Special thanks also to @pce-europe.bsky.social for participating at the event 💜
#pancreaticcancer #cancersummit
- descubrimiento de una variante genética que aumenta el riesgo (Francisco X. Real)
- avances hacia una biopsia líquida que permita la detección precoz con un análisis de sangre (Nuria Malats y @hps2022.bsky.social en @pancaid.bsky.social )
Today is #WorldPancreaticCancerDay 💜
#Pancreaticcancer is projected to become the second leading cause of cancer-related deaths in Western societies by 2030. A stark reminder of why our work matters.
Today, our thoughts are with all patients and families affected by this devastating disease. 💜
#WPCD
Honored to host the 3rd Annual Cluster Meeting of the Prevention & Early Detection (Screening) Cluster in Brussels.
We're joined by our cluster members MammoScreen, DIOPTRA, SANGUINE, LUCIA, and @oncoscreen-project.bsky.social.
@horizoneu.bsky.social @ec.europa.eu #CancerPrevention #EarlyDetection
Such a pleasure to lead this consortium together with #klauspantel from #UKE! @ki.se is participating with several departments including #CLINTEC, #LIME, #NVS #yvonnewengström #niklaszethraeus
Writing from #Brussels @ec.europa.eu where we are meeting for our 🇪🇺 project @pancaid.bsky.social #pancreaticcancer is still a medical emergency!
In the afternoon sessions, we discuss work packages 1 – 3, first each progress separately, then jointly in a planum discussion.
1️⃣ Patient cohorts & sample collection
2️⃣ #liquidbiopsy diagnostis
3️⃣ AI analysis & data management
#PancSky
We just had our PANCAID ECS session, where each ECS gave an update on their individual research projects.
Thank you to Ebba Asplund, Kim-Lea Reese, Robert Wittram, Pabolo Villoslada-Blanco, Sergio Sabroso and Mireia Andueza for your presentations and contributions!
#pancreaticcancer #earlydetection
Bonjour and goedendag from Brussels! Our 4th PANCAID General Assembly Meeting just kicked off with a masterclass shared by Klaus Pantel and Catherine Alix-Panabieres, on #Liquidbiopsy diagnostics
#pancreaticcancer
@cathiepana.bsky.social
Both @nuriamalats.bsky.social & me at @champalimaudf.bsky.social 2nd International meeting on #pancreaticcancer @peterbaileychamp.bsky.social from the #PANCAIM / #PANORAMA @radboudumc.bsky.social and @pancaid.bsky.social @euprojectpulse.bsky.social EU projects! Great discussions w/ our US friends!
How is #AI transforming early cancer detection?
Experts from @phireproject.bsky.social, PANCAIM and PANCAID explore how data, innovation & collaboration drive precision oncology.
🎙 Moderated by Federica Zanca (EIC)
📺 Watch now: www.youtube.com/watch?v=aUhZ...
#CancerResearch #AIinOncology
🚨 Just 2 days left to register!
Join us on 15 Oct, 14:00 CEST for our webinar on AI in early cancer detection with @phireproject.bsky.social , @pancaid.bsky.social, and #PANCAIM
🔗 Register now: https://tinyurl.com/PPPWebinarOnAI
#AIinOncology #CancerResearch
